DuPont Closes Licensing Deal on DNA Technology via yet2.com
Boston MA, 16 April 2006—yet2.com announced that it facilitated the closing of a technology licensing deal for DuPont on a DNA manipulation technology. The licensee and the terms of the deal were not disclosed.
“We believe the future of licensing technology is a greater number of smaller deals. Yet2.com is a key partner in facilitating these kinds of deals,” said Chip Murray, Managing Director of DuPont Intellectual Assets and Licensing business.
“Large-company-to-small-company technology licensing deals are an important part of our business. We believe these kinds of deals will be in great demand in the future,“ said Phil Stern, CEO of yet2.com.
DuPont is a science company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel.
For more information, visit www.dupont.com
Yet2.com provides intellectual property consulting and licensing services to world-class clients around the globe. Yet2.com Inc and its online marketplace were founded in 1999 to promote technology licensing and transfer, with joint investment from Siemens, Bayer, Honeywell, Dupont, Procter & Gamble, Caterpillar, and NTT Leasing. The privately held company has offices in the United States, Europe, and Japan. Its clientele consists of a quarter of the Fortune 1000. Yet2.com draws upon its global network of technology leaders in thousands of companies across all industries, to establish productive dialogs quickly.
For more information, visit www.yet2.com.
Tim Bernstein 1 781-972-0600